Cellosaurus Panc02 (CVCL_D627)
| Cell line name | Panc02 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | Panc-02; Panc 02; Pan02; Pan-02; PAN 02; Panc02-H0 | ||||||||||||||||
| Accession | CVCL_D627 | ||||||||||||||||
| Resource Identification Initiative | To cite this cell line use: Panc02 (RRID:CVCL_D627) | ||||||||||||||||
| Comments | Doubling time: 61 hours (PubMed=24278292). Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA). Derived from site: In situ; Pancreas; UBERON=UBERON_0001264. | ||||||||||||||||
| Disease | Mouse pancreatic ductal adenocarcinoma (NCIt: C34041) | ||||||||||||||||
| Species of origin | Mus musculus (Mouse)
(NCBI Taxonomy: 10090)
Breed/subspecies: C57BL/6. | ||||||||||||||||
| Hierarchy | Children:
| ||||||||||||||||
| Sex of cell | Male | ||||||||||||||||
| Category | Cancer cell line | ||||||||||||||||
| STR profile | Source(s): Ubigene=YC-C067 Markers:
Run an STR similarity search on this cell line | ||||||||||||||||
| Publications | PubMed=6692374 PubMed=11558631; DOI=10.1385/IJGC:29:1:37 PubMed=20805420; DOI=10.4049/jimmunol.0902609; PMCID=PMC3693576 PubMed=21720167; DOI=10.1159/000329413 PubMed=22208613; DOI=10.2174/156652412799218868; PMCID=PMC3799885 PubMed=24278292; DOI=10.1371/journal.pone.0080580; PMCID=PMC3835415 | ||||||||||||||||
| Cross-references | |||||||||||||||||
| Cell line collections (Providers) | CLS; 300501
NCI-DTP; PAN 02 Ubigene; YC-C067 | ||||||||||||||||
| Cell line databases/resources | CCRID; 1101MOU-PUMC000446 | ||||||||||||||||
| Anatomy/cell type resources | BTO; BTO_0005175 | ||||||||||||||||
| Chemistry resources | ChEMBL-Cells; CHEMBL4483161
ChEMBL-Targets; CHEMBL4483283 PubChem_Cell_line; CVCL_D627 | ||||||||||||||||
| Encyclopedic resources | Wikidata; Q54937552 | ||||||||||||||||
| Entry history | |||||||||||||||||
| Entry creation | 22-Oct-2012 | ||||||||||||||||
| Last entry update | 27-Nov-2025 | ||||||||||||||||
| Version number | 18 | ||||||||||||||||